Iterum Therapeutics plc (ITRM) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Cash from Operations | -7.85M | -4.75M | -3.06M | -4.26M | -2.67M | -6.76M | -13.08M | -12.84M | -9.27M | -7.63M | -9.59M | -4.26M | -4.54M | -6.02M | -3.4M | -2.46M | -3.91M | -8.34M | -1.13M | -9.03M |
| Operating CF Margin % | -2012.21% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -193.7% | 29.71% | 76.61% | 66.86% | 71.16% | 11.44% | -36.42% | -201.13% | -104.12% | -26.86% | -181.64% | -73.44% | -16.09% | 27.88% | -200.8% | 72.77% | 11.48% | 39.07% | 95.87% | 54.88% |
| Net Income | -8.98M | -6.51M | -4.89M | -6.58M | -6.09M | -5M | -7.1M | -12.36M | -3.88M | -12.24M | -9.89M | -5.09M | -29.11M | -6.74M | -3.5M | -4.18M | 3.74M | 7.8M | -98.92M | -11.19M |
| Depreciation & Amortization | 355K | 351K | 349K | 261K | 8K | 8K | 7K | 440K | 436K | 438K | 436K | 439K | 448K | 455K | 458K | 1.77M | 730K | 185K | 35K | 39K |
| Stock-Based Compensation | 0 | 56K | 61K | 89K | 68K | 68K | 138K | 139K | 142K | 110K | 393K | 457K | 422K | 0 | 1.9M | 1.97M | 1.51M | 559K | 281K | 126K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13.2M | 960K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.82M | 1.52M | 1.69M | 3.4M | 3.42M | 1.64M | 1.63M | 1.24M | 1.3M | 1.26M | 2.19M | -2.42M | 23.51M | 1.54M | -3.31M | -1.82M | -9.53M | -14.67M | 93.22M | 6.26M |
| Working Capital Changes | -1.04M | -171K | -266K | -1.42M | -73K | -3.48M | -7.76M | -2.29M | 5.93M | 1.84M | -2.72M | 2.35M | 190K | -1.28M | 1.05M | -193K | -361K | -2.21M | 4.25M | -4.27M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -217.28K | -415K | -533K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -633.19K | 777K | 161K | -584K | 14K | -2.14M | -2.03M | -518K | 1.8M | 1.48M | -539K | 1.54M | 443K | 0 | -195K | 603K | 0 | 92K | 1.04M | -1.79M |
| Cash from Investing | -12.57K | 0 | -2K | 1.1M | 5.7M | 4.2M | 7.21M | 13.52M | 360K | 4.35M | 5.11M | 4.38M | 15.85M | -15.7M | 9.59M | -4.47M | 4.93M | -21.14M | -33.92M | 0 |
| Capital Expenditures | -12.57K | 0 | -2K | 0 | 0 | -2K | 0 | 0 | 3K | -16.11K | 0 | -45K | -7K | -9.74K | 0 | -13K | -48K | 0 | 0 | 0 |
| CapEx % of Revenue | 3.22% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -357 | 16.11K | 0 | -4.42K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 357 | -16K | 0 | 4.42K | 0 | 0 | 0 | 0 | 4.98M | 0 | 0 | 0 |
| Cash from Financing | 5.66M | 5.12M | -8.39M | 13.88M | 5.43M | 167K | 7.22M | 589K | 10K | 200K | 235K | 433K | 0 | 57.77K | -2.25M | -1.63M | -1.63M | -592K | 86.98M | 15.13M |
| Debt Issued (Net) | -109.46K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 57.77K | -2.25M | -1.63M | -1.63M | -1.63M | -1.63M | -1.58M |
| Equity Issued (Net) | 5.77M | 5.12M | 6.36M | 13.88M | 5.43M | 167K | 7.22M | 589K | 10K | 200K | 235K | 433K | 0 | 0 | 0 | 0 | -5K | 1.04M | 88.61M | 25.27M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5K | 0 | 0 | 0 |
| Other Financing | 0 | 0 | -14.74M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.56M |
| Net Change in Cash | -2.02M | 374K | -11.47M | 10.72M | 8.43M | -2.41M | 1.32M | 1.25M | -8.92M | -3.1M | -4.26M | 573K | 11.28M | -22.12M | 3.92M | -8.54M | -621K | -30.07M | 51.92M | 6.12M |
| Free Cash Flow | -7.86M | -4.75M | -3.06M | -4.26M | -2.67M | -6.76M | -13.08M | -12.84M | -9.26M | -7.65M | -9.59M | -4.31M | -4.55M | -6.03M | -3.4M | -2.47M | -3.96M | -8.34M | -1.13M | -9.03M |
| FCF Margin % | -2015.43% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -194.17% | 29.73% | 76.6% | 66.86% | 71.15% | 11.6% | -36.42% | -197.98% | -103.74% | -26.93% | -181.64% | -74.35% | -14.86% | 27.76% | -200.8% | 72.63% | 10.57% | 39.08% | 95.87% | 54.89% |
| FCF per Share | -0.17 | -0.12 | -0.09 | -0.22 | -0.13 | -0.41 | -0.85 | -0.97 | -0.71 | -0.59 | -0.76 | -0.32 | -0.37 | -0.49 | -0.28 | -0.19 | -0.29 | -0.61 | -0.14 | -3.33 |
| FCF Conversion (FCF/Net Income) | 0.87x | 0.73x | 0.63x | 0.65x | 0.44x | 1.35x | 1.84x | 1.04x | 2.39x | 0.62x | 0.97x | 0.84x | 0.16x | 0.89x | 0.97x | 0.59x | -1.05x | -1.07x | 0.01x | 0.81x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22K | 55K | 88K | 121K | 152K | 229K |
| Taxes Paid | 0 | 81K | 0 | 0 | 0 | 220K | 0 | 281K | 109K | 0 | 11K | 0 | -77K | 0 | 0 | 38K | 0 | 322K | 0 | 31K |